Nu-Med (NUMD) 0.3490 $NUMD Nu-Med Plus Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nu-Med (NUMD) 0.3490 $NUMD

Nu-Med Plus Announces Investigational Study of Stored Blood as a New Path for Their NO Devices
Marketwire Canada - Tue May 10, 7:02AM CDT
SALT LAKE CITY, UT--(Marketwired - May 10, 2016) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announces they are embarking on a new investigational study applying their patent pending nitric oxide delivery devices to the protection of stored blood. Prior investigation studies have shown that adding nitric oxide to stored blood has several beneficial effects that could lead to a better stored blood product. Management has identified the estimated $4 billion dollar US blood market as a strategic product development project that will add significant value to Nu-Med.

Nu-Med Plus Inc. Announces New Proprietary Source for Low Cost Nitric Oxide Technology
Marketwired - Tue May 03, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced through its continuous improvement process it has created a new environmentally conscious method of generating nitric oxide gas for use in its medical gas delivery systems. Nitric oxide is a medically essential gas that is presently used in Neonate Hypoxia therapy (inadequate oxygen level in newborns), pulmonary treatments and may have future applications for a variety of other diseases and complications that are currently being investigated.

Nu-Med Plus Inc. Files Utility Patent for Low Cost Inhaled Nitric Oxide Technology
Marketwired - Tue Jan 26, 7:02AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced filing for a utility patent as continuation of its provisional patent which covers its low cost Nitric Oxide delivery technology.

Nu-Med Plus submits patent application for portable rapid distribution inhaled nitric oxide generator
M2 - Thu Jan 21, 5:14AM CST
Medical device company Nu-Med Plus (OTCBB:NUMD) announced on Wednesday that it has filed a patent for its new portable rapid distribution Nitric Oxide generating technology.

Nu-Med Plus, Inc. Applies for Patent on Portable Rapid Distribution Inhaled Nitric Oxide Generator
Marketwired - Wed Jan 20, 7:01AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its new portable rapid distribution Nitric Oxide generating technology.

Nu-Med Plus reports newly developed inhaled nitric oxide generation system
M2 - Fri Jan 15, 6:27AM CST
Medical device company Nu-Med Plus (OTCBB:NUMD) said on Thursday that it has developed a new delivery system and formulation for the generation of inhaled nitric oxide for potential therapeutic use outside hospital and clinical environments.

Nu-Med Plus Develops Portable Rapid Distribution Nitric Oxide Generator
Marketwired - Thu Jan 14, 7:01AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced the development of a new delivery system and formulation for the generation of inhaled nitric oxide for potential therapeutic use outside the hospital and clinical environment. The newly developed system uses the thermal decomposition of a complex compound as the source of nitric oxide.

Nu-Med Plus, Inc. Raises Funding for Completion of Inhaled Nitric Oxide (INO) Clinical Unit
Marketwired - Tue Dec 08, 7:00AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has received interim funding thru the guidance of Smith Corporate Services to accelerate the completion of its INO clinical device designed for low cost use in out-patient and medical office settings.

Nu-Med Plus Contacted by Global Medical Healthcare Provider
Marketwired - Wed Sep 09, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has been contacted by a major producer of gases for Industry, Health and the Environment to discuss Nu-Med Plus's approach to Inhaled Nitric Oxide(NO) delivery.

Nu-Med Plus Announces the Addition of Keith L. Merrell as Their Chief Financial Officer
Marketwired - Tue Aug 04, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced that Keith L. Merrell has accepted the position of Chief Financial Officer replacing Mark Christensen.

Nu-Med Plus Announces New Methodology Using Nitric Oxide for Diabetic Wound Healing
Marketwired - Tue Jul 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced today that it has created the design and methodology by which Nitric Oxide (NO) may well be safely delivered, at optimal levels, to facilitate in the therapeutic healing of chronic diabetic foot ulcers and wounds.

Nu-Med Plus, Inc. Selects NT Associates as Its Strategic Public Relations Partner
Marketwired - Tue Jul 14, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm NT Associates as its strategic public relations partner. NT Associates will be responsible for directing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.

Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase
Marketwired - Tue Jul 07, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has drawn worldwide attention with the increased threats to national economies coming from the spread of MERS, SARS and the Bird Flu.

Nu-Med Plus Announces Increased Patient Safety of Portable Inhaled Nitric Oxide Delivery
Marketwired - Tue Jun 30, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced that a visual indicator has been created that increases the safe therapeutic delivery of nitric oxide. The indicator is a quick visual check to ensure that by-products of the delivery of nitric oxide are not present in potentially toxic levels.

Nu-Med Plus, Inc. Selects Affinity Advisors, LLC as Their Strategic Public Relations Partner
Marketwired - Tue Jun 16, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm Affinity Advisors as its strategic public relations partner. Affinity Advisors will be responsible for strategizing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.

Nu-Med Plus Announces Computer Based Analyzer for Their Portable Inhaled Nitric Oxide System
Marketwired - Tue May 19, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a computer based analyzer and calibration software to complement their Portable/Rechargeable Inhaled Nitric Oxide unit. The completion of the analyzer is another step in providing a total solution for the administration of nitric oxide in a non-hospital setting. It is designed to be intuitive and simple to use.

Nu-Med Plus, Inc. Applies for Patent on Portable/Rechargeable Inhaled Nitric Oxide Delivery System
Marketwired - Tue May 05, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its Portable Inhaled Nitric Oxide delivery technology.

Nu-Med Plus Announces the Addition of Charles Ivester M.D., Ph.D., to Their Medical Advisory Board
Marketwired - Tue Apr 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Charles Ivester M.D., Ph.D. to their Medical Advisory Board.

Nu-Med Plus elects Mark Christensen as CFO
M2 - Tue Apr 21, 8:42AM CDT
Medical device company Nu-Med Plus (OTCBB:NUMD) disclosed on Tuesday the addition of Mark Christensen MPrA, CPA as its chief financial officer.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 394

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 168

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Allegations Against Symbotic Inc: The Investor Angle

Updated Category News Views 31

Allegations Rock Symbotic Inc. The ink is barely dry on the reports that some fat cats at Symbotic Inc. might've let their fingers get a bit too close to the cash till. There's a whirlwind brewing, pointing the finger squarely at the boardroom. Halper Sadeh LLC, the legal big shots known for scrutinizing shifty corporate moves, have thrown down the gauntlet, probing...

Continue Reading
David Lazar's Acquisition of Preferred Stock in Cyclacel

Updated Category News Views 210

Cyclacel Pharmaceuticals Engages Investor David Lazar for Preferred Stock Purchase Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) has taken a notable step forward by entering into a strategic agreement with investor David Lazar for the acquisition of preferred stock. This agreement is heralding a new chapter in Cyclacel’s mission to develop innovative...

Continue Reading
TSC Alliance 50 Forward Fund Launches to Advance Research

Updated Category News Views 529

TSC Alliance Unveils 50 Forward Fund to Transform Research In a significant move aiming to revolutionize the lives of those affected by tuberous sclerosis complex (TSC), the TSC Alliance has launched the public phase of its 50 Forward Fund. This ambitious fundraising campaign is targeting a remarkable $40 million to drive forward research that promises to change the...

Continue Reading
What to Watch in the Stock Market Today - May 23, 2024

Updated Category Markets Views 359

Market Overview: Key Factors Influencing Stocks on May 23, 2024 Financial markets, especially the stock markets, are constantly fluctuating, and as it stands now, same for today, May 23, 2024. Market participants intend to deal for a number of earning calls, economic releases and geopolitical events that might turn the markets north or south. Thus, let’s go deeper into...

Continue Reading
Polish Stocks Surge as WIG30 Index Rises Significantly Today

Updated Category News Views 90

Positive Trends in Poland's Stock Market Today, the Polish stock market demonstrated a strong performance, with significant gains across multiple sectors as the day drew to a close. The WIG30 index, a prominent measure of stock performance in the nation, increased by 1.68%. This uplift was largely driven by growth in the Basic Materials, Construction, and Banking sectors....

Continue Reading